Chemical Reviews· 2019Q1· Review
Reactive Oxygen Species (ROS)-Based Nanomedicine
- 2,428citations
- Q1SCImago
- 2019year
Short summary
Nanomaterials can be engineered to control reactive oxygen species (ROS) for therapeutic purposes, leading to a new field of 'ROS science' that integrates chemistry, biology, and nanotherapy.
AI-generated from the title and abstract; the full text is not read.
Key points
- Nanomaterials can guide the temporospatial dynamics of ROS in biological systems.
- This leads to a new therapeutic methodology: nanomaterial-guided in vivo ROS evolution.
- The concept of 'ROS science' is proposed, integrating ROS chemistry, biology, and nanotherapy.
- Focus is on material chemistry enabling ROS generation or scavenging for improved therapy.
AI-generated from the title and abstract; the full text is not read.
Abstract
Reactive oxygen species (ROS) play an essential role in regulating various physiological functions of living organisms. The intrinsic biochemical properties of ROS, which underlie the mechanisms necessary for the growth, fitness, or aging of living organisms, have been driving researchers to take full advantage of these active chemical species for contributing to medical advances. Thanks to the remarkable advances in nanotechnology, great varieties of nanomaterials with unique ROS-regulating properties have been explored to guide the temporospatial dynamic behaviors of ROS in biological milieu, which contributes to the emergence of a new-generation therapeutic methodology, i.e., nanomaterial-guided in vivo ROS evolution for therapy. The interdependent relationship between ROS and their corresponding chemistry, biology, and nanotherapy leads us to propose the concept of "ROS science", which is believed to be an emerging scientific discipline that studies the chemical mechanisms, biological effects, and nanotherapeutic applications of ROS. In this review, state-of-art studies concerning recent progresses on ROS-based nanotherapies have been summarized in detail, with an emphasis on underlying material chemistry of nanomaterials by which ROS are generated or scavenged for improved therapeutic outcomes. Furthermore, key scientific issues in the evolution of ROS-based cross-disciplinary fields have also been discussed, aiming to unlock the innate powers of ROS for optimized therapeutic efficacies. We expect that our demonstration on this evolving field will be beneficial to the further development of ROS-based fundamental researches and clinical applications.
The authors' abstract, as published at the source. Chemical Reviews, 2019 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Biomedical Engineering
Biomedical EngineeringEngineering